drugset / Trial / NCT00768209
A Study to Evaluate the Pharmacokinetics of VI-0521 in Subjects With Hepatic Impairment
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study is designed to determine the effects of a single dose of the study medication in subjects with and without hepatic impairment. 18 to 24 subjects will participate by having multiple blood draws taken to measure the level of study medication in their blood over time.
Timeline
- Start
- 2008-10
- Primary completion
- 2009-03
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Phentermine | Small molecule | 15 mg | Oral |
| Subject | Topiramate | Small molecule | 92 mg | Oral |
Indications
No indication recorded.